Veterinary Medicines Internal Market Scheme (VMIMS)

VMIMS allows veterinary surgeons in Northern Ireland to prescribe and use veterinary medicines authorised only in Great Britain, under certain exceptional conditions, where no Northern Ireland or EU-authorised medicine is available.

Effective from 1 January 2026 - Applies to Northern Ireland

This scheme is case-by-case and aims to avoid unacceptable animal suffering.

Key Features of VMIMS:

  • Removes the requirement for a certificate to move GB-authorised veterinary medicines into NI.
  • Supports medicine use under the cascade, as set out in Articles 112, 113, and 114 of Regulation (EU) 2019/6.

Eligibility Criteria:

1. No authorised and available alternative in NI or the EU.
2. The medicine:
  • Must be supplied from Great Britain to Northern Ireland.
  • Must hold a current Marketing Authorisation (MA) in Great Britain.
  • Cannot be an immunological veterinary medicine
3. Use must fall under the cascade system.

Veterinary Medicine Health Situation Scheme:

This scheme may be triggered in exceptional public or animal health situations that cannot be addressed through:
  • The cascade, or
  • The VMIMS.

In such cases, the Veterinary Medicines Directorate (VMD) may temporarily authorise the use of suitable alternative veterinary medicines from the EU.

Purpose:

To enable rapid response in the event of urgent animal or public health risks, when existing authorisation pathways are inadequate.

For further Information please visit:

GOV.UK – Veterinary Medicines Internal Market Scheme

GOV.UK – Veterinary Medicine Health Situation